Prevalence of alloimmunisation in patients with beta thalassaemia major

Blood Transfusion

Volumn 10, Issue 3, 2012, Pages 396-397

  Kosaryan, Mehrnoush ^a   Mahdavi, Mohammad Reza ^a   Roshan, Payam ^a   Hojjati, Mohammad Taher ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; BLOOD TRANSFUSION; HUMAN; IRAN; LETTER; PREGNANCY; SICKLE CELL ANEMIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; FEMALE; HUMANS; IRAN; ISOANTIBODIES; MALE; PREVALENCE;

EID: 84865159173     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0072-11     Document Type: Letter

References (5)

1. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37: 12-20.
2. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who receivedtransfusions. Transfusion 2002; 42: 37-43.
3. Bhatti FA, Salamat N, Nadeem A, Shabbir N. Red cell immunization in beta thalassaemia major. J Coll Physicians Surg Pak 2004; 14: 657-60.
4. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999; 39: 763-71.
5. Gupta R, Singh B, Rusia U, Goyal S. Red Cell alloimmunization in routinely transfused patients of beta thalassemia major. IJBTI 2010; 1: 1-4.